These results coupled with the analysis here communicated and the possible cross-recognition of the GDP-L-fucose synthase enzyme from gut microbiota suggest a possible role of some components of this microbiota as a trigger of pathogenic autoimmune responses in MS. Here, GFUS is linked to myeloid sarcoma.